Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06421350 · ClinicalTrials.gov registry record · NA

Closed Loop Spinal Cord Stimulation for Complex Regional Pain Syndrome

A NA study of Complex Regional Pain Syndromes, sponsored by Scripps Health.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT06421350 is a NA study of Complex Regional Pain Syndromes that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 32 participants, below the 102-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06421350, a NA study of Complex Regional Pain Syndromes, is actively recruiting participants, sponsored by Scripps Health.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to determine the differences in response to treatment of complex regional pain syndrome with a closed-loop spinal cord stimulator if applied in the early phases (acute or subacute) versus the chronic phase.

Interventions

  • DEVICE Spinal Cord Stimulation Device

Study Locations (1)

California

  • Scripps Clinic Torrey Pines - La Jolla

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-09-03
Est. Completion 2026-06
Phase NA

Sponsor

Scripps Health

30 total trials

What the Registry Record Tells You About NCT06421350

The ClinicalTrials.gov registry entry for NCT06421350 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (69% lower). The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Complex Regional Pain Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulation Device is the first listed.

NCT06421350 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06421350 about?

NCT06421350 is a clinical study titled "Closed Loop Spinal Cord Stimulation for Complex Regional Pain Syndrome". The primary purpose of this study is to determine the differences in response to treatment of complex regional pain syndrome with a closed-loop spinal cord stimulator if applied in the early phases (acute or subacute) versus the chronic phase.

What is the current status of trial NCT06421350?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-09-03. Estimated completion is 2026-06.

What conditions does trial NCT06421350 study?

This clinical trial studies the following conditions: Complex Regional Pain Syndromes.

What interventions are being tested in trial NCT06421350?

The interventions under investigation include: Spinal Cord Stimulation Device (DEVICE).

Who is sponsoring clinical trial NCT06421350?

This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06421350 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Complex Regional Pain Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.